Phaarmasia Ltd
Phaarmasia Ltd Live Price Chart
Phaarmasia Ltd Technicals
| 20 Day | ₹ 104.867 |
| 50 Day | ₹ 96.042 |
| 100 Day | ₹ 78.592 |
| 200 Day | ₹ 62.029 |
| 20 Day | ₹ 110.252 |
| 50 Day | ₹ 100.749 |
| 100 Day | ₹ 68.700 |
| 200 Day | ₹ 49.843 |
Phaarmasia Ltd Performance
| Previous Close | ₹ 98.7 |
| High | ₹ 103.63 |
| Volume | 1362 |
| 52W Range | ₹ 23.6 - ₹ 131.75 |
| Open | ₹ 99.19 |
| Low | ₹ 93.77 |
| Market Cap | ₹ 52 Cr |
Phaarmasia Ltd Fundamentals
| ROCE | 7.840 |
| P/E Ratio | 90.900 |
| P/B Ratio | 10.880 |
| Industry P/E | 10.880 |
| Debt to Equity | 39.451 |
| ROE | 7.277 |
| EPS | 1.140 |
| Dividend Yield | 0.000 |
| Book Value | 9.523 |
| Face Value | 10.000 |
Phaarmasia Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 25.1151 | 31.2548 | 28.0056 | 17.6855 | 20.7888091 |
| Total Expenses | 26.7178 | 31.8007 | 29.4376 | 19.2477 | 20.3100981 |
| Profit After Tax | -1.5894 | -0.5182 | -1.2592 | -1.5472 | 0.3119863 |
Phaarmasia Ltd Shareholding Pattern
| Promoter Holdings | 73.513 % |
| FIIs | 0.004 % |
| DIIs | 0.055 % |
| MutualFund | 0.000 % |
| Retail | 25.810 % |
| Others - | 0.619 % |
About Phaarmasia Ltd
History of Phaarmasia Ltd
Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR. During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP certified and ISO 9001-certified manufacturing facility. ...
